Neurogene (NGNE) Change in Acquisitions & Divestments (2014 - 2026)

Neurogene has reported Change in Acquisitions & Divestments for 10 years, with the latest figure at $130.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments rose 190.83% year-over-year to $130.0 million; the trailing twelve-month figure through Mar 2026 stood at $370.0 million (up 317.14% YoY), and the FY2025 full-year result was $284.7 million, up 284.73% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $130.0 million, up from $72.5 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $130.0 million in Q1 2026, with the low at -$15.0 million in Q4 2022.
• Historically, Change in Acquisitions & Divestments has averaged $41.1 million across 5 years, with a median of $24.8 million in 2024.
• The largest YoY upside for Change in Acquisitions & Divestments was 1037.14% in 2025 against a maximum downside of 49.0% in 2025.
• Neurogene's Change in Acquisitions & Divestments stood at -$15.0 million in 2022, then soared by 133.33% to $5.0 million in 2023, then soared by 215.0% to $15.8 million in 2024, then surged by 360.32% to $72.5 million in 2025, then soared by 79.31% to $130.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $130.0 million (Q1 2026), $72.5 million (Q4 2025), and $99.5 million (Q3 2025), per Business Quant data.